title: Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma.
authors.affiliation: University of Wisconsin, Madison, Wisconsin.
authors.forename: Ray R
authors.initials: RR
authors.lastname: Zhang
authors.forename: Kelli B
authors.initials: KB
authors.lastname: Pointer
authors.forename: John S
authors.initials: JS
authors.lastname: Kuo
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Dempsey
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000188:drug therapy / Q000235:genetics*; D002471:Cell Transformation, Neoplastic / Q000187:drug effects*; D003606:Dacarbazine / Q000031:analogs & derivatives / Q000627:therapeutic use; D005910:Glioma / Q000188:drug therapy / Q000235:genetics*; D006801:Humans; D009154:Mutation; D009364:Neoplasm Recurrence, Local / Q000235:genetics*; D000077204:Temozolomide
chemical_list: D000970:Antineoplastic Agents; D003606:Dacarbazine; D000077204:Temozolomide